Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.33% | 161.91 | 0.0% | $1904.75m | |
| OCGN | Ocugen, Inc. | 1.26% | 8.86 | 0.0% | $1093.41m | |
| BNTX | BioNTech SE | 0.55% | 193.82 | 0.0% | $877.28m | |
| AMGN | Amgen, Inc. | 0.00% | 251.38 | 1.3% | $740.91m | |
| NVAX | Novavax, Inc. | 1.00% | 133.00 | 79.8% | $578.20m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 7.68 | 0.7% | $536.86m | |
| GILD | Gilead Sciences, Inc. | -0.18% | 68.41 | 1.0% | $503.67m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 516.62 | 2.7% | $432.65m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.00% | 173.49 | 2.0% | $412.31m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.00% | 214.91 | 1.9% | $308.42m | |
| ILMN | Illumina, Inc. | 0.00% | 381.03 | 3.5% | $302.74m | |
| BIIB | Biogen, Inc. | 0.00% | 280.21 | 1.7% | $269.43m | |
| VXRT | Vaxart, Inc. | -2.42% | 6.45 | 0.0% | $234.96m | |
| CRSP | CRISPR Therapeutics AG | 0.05% | 106.69 | 0.6% | $171.49m | |
| BNGO | Bionano Genomics, Inc. | -2.78% | 5.25 | 0.0% | $158.24m |
Company Profile
Ikena Oncology, Inc. is a clinical stage biotechnology company. It discovers and develops patient directed, biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412 and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.